Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2025-12-19 00:00:00 ET · period of report 2025-11-01 · accession 0001159036-25-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-19 | 2025-11-01 | HALO | Caudill Cortney | SVP, COO | M - OptEx | $0.00 | +9,326 | 17.0K | +122% | $0 |
| D | 2025-12-19 | 2025-11-01 | HALO | Caudill Cortney | SVP, COO | S - Sale+OE | $65.19 | -4,263 | 12.7K | -25% | -$277.9K |
| D | 2025-12-19 | 2025-11-01 | HALO | Caudill Cortney | SVP, COO | M - OptEx | $0.00 | -9,326 | 18.7K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-01 | M | A | 9,326 | $0.00 | 17,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-01 | S | D | 4,263 | $65.19 | 12,737 | D | — | — | (F1) The reported disposition of 4,263 shares represents the shares that were withheld and sold by the issuer as payment for tax withholding obligations. |
| 3 | Derivative | Restricted Stock Units | 2025-11-01 | M | D | 9,326 | $0.00 | 18,651 | D | $0.00 · — to — | 9,326 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |